- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Based on the Iron (Fe) and Atherosclerosis Study (FeAST).ppt
Based on the Iron (Fe) and Atherosclerosis Study (FeAST) FeAST Trial: Background Accumulation of iron in excess of physiologic requirements has been implicated in risk of cardiovascular disease because of increased iron-catalyzed free radical-mediated oxidative stress. The objective of this study was to test the hypothesis that reducing body iron stores through phlebotomy will influence outcomes in a cohort of patients with symptomatic peripheral arterial disease (PAD). FeAST Trial: Primary and Secondary Outcome Events FeAST Trial: Kaplan-Meir Analysis of Primary Endpoint (All-Cause Mortality) FeAST Trial: Kaplan-Meir Analysis of Secondary Endpoint (Death Plus Nonfatal MI, or Stroke) FeAST Trial: Limitations Because of lower than expected accrual, the study was underpowered overall and particularly underpowered to definitively assess outcomes in younger patients and smokers. This study was single-blinded, and primary and secondary endpoints were adjudicated by a committee external to the study; nonetheless, concerns remain about possible bias, particularly in subgroup analyses. FeAST Trial: Limitations (cont.) Patients with very high ferritin levels were excluded from the study, and the efficacy of iron reduction in individuals with extreme levels of iron stores is unknown. FeAST Trial: Summary Preplanned analyses of the primary (all-cause mortality) and the secondary (death plus nonfatal MI and stroke) endpoints performed on the entire study cohort showed no effect of iron reduction. However, there was a significant interaction with age (1of 5 prespecified biological stratifying factors), suggesting that a beneficial effect might exist in younger patients, and observation that coincides with findings of others. FeAST Trial: Summary (cont.) The FeAST data show that it should be possible to test definitively whether controlling iron levels may reduce disease risk and additional research is needed to further define ferrotoxic diseases, stratifying risk reduct
您可能关注的文档
最近下载
- 关于印发《关于推动中央企业加快司库体系建设进一步加强资金管理的意见》的通知.docx VIP
- 转炉和阳极炉讲解.ppt VIP
- 往届二外小升初分班数学测试卷(有答案).pdf VIP
- 2025年全国中小学校党组织书记网络培训示范班在线考试题库及答案.pdf VIP
- 《水利水电工程施工监理规范sl288-2014表格》2016年1月更新.docx VIP
- 线路题库维护考试题库汇总.docx VIP
- 轮毂设计验证计划和报告(DVP&R).xls VIP
- 2025年国家低压电工作业证理论考试题库(含答案).pdf
- 新版GMP口服固体制剂多品种共线生产风险评估报告.pdf VIP
- 重庆某220kv变电站工程施工组织设计(精品).doc VIP
文档评论(0)